Am J Transplant, Volume 22, Suppl 3 Archives - Page 53 of 190 - ATC Abstracts

2022 American Transplant Congress
An Analysis of Serological Response and Infection Outcomes Following Oxford Astra-Zeneca (azd1222) and Pfizer-Biontech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Pancreas Transplant Patients
A. Asderakis¹, U. Khalid¹, G. Koimtzis¹, M. Ponsford², L. Szabó¹, L. Grant², S. Jolles², I. Humphreys³
¹Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom, ²Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom, ³Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom
*Purpose: SARS-CoV-2 is associated with high mortality among transplant recipients. This study aims to compare the humoral responses between the Oxford-Astra-Zeneca(AZ) and BNT162b2(Pfizer-BioNTech) vaccines in…
2022 American Transplant Congress
Pulsatile Kidney Perfusion Improves Survival and Graft Function in High Acuity Combined Liver Kidney Transplant (CLKT) Recipients
T. Liu¹, G. Panayotova², F. Paterno³, A. Amin², L. Brown⁴, J. Guarrera⁵, K. Lunsford⁶
¹Surgery, Rutgers New Jersey Medical School, Newark, NJ, ²Division of Transplant and Hepatobiliary Surgery, Rutgers New Jersey Medical School, Newark, NJ, ³Rutgers State University of New Jersey, Montclair, NJ, ⁴Rutgers New Jersey Medical School, Morris Plains, NJ, ⁵Surgery/ Transplant, Rutgers New Jersey Medical School, Newark, NJ, ⁶Rutgers New Jersey Medical School, Newark, NJ
*Purpose: Due to underlying renal dysfunction, CLKT recipients tend to have higher medical acuity at baseline resulting in a higher likelihood of post-operative complications and…
2022 American Transplant Congress
Stabilization of Cell-Cell Junctions Improves Outcomes in an Ex-Vivo Porcine Renal Ischemia-Reperfusion Injury Culture Model
L. Plumblee¹, K. Patel², L. Langerude³, Z. Tu³, D. Nord⁴, T. Beduschi³, S. Nadig⁵, C. Atkinson⁶
¹MUSC College of Medicine, Gainesville, FL, ²University of Virgina, Charlottesville, VA, ³University of Florida, Gaineville, FL, ⁴Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL, ⁵Northwestern University, Charleston, SC, ⁶Pulmonary Medicine, University of Florida, Gainesville, FL
*Purpose: Renal transplant is an accepted therapy for end-stage renal failure. Chronic transplant dysfunction remains the leading cause of long-term graft loss and is, in…
2022 American Transplant Congress
Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation
E. Takoushian¹, E. Brandon¹, B. Samstein², K. Halazun²
¹Liver Transplantation, New York Presbyterian Weill Cornell, New York, NY, ²Weill Cornell Medical Center, New York, NY
*Purpose: LT is a novel therapy for patients with unresectable CRLM. 5 year survival using LT appears to be significantly better than systemic chemotherapy in…
2022 American Transplant Congress
Use of Targeted T-Cell Therapy (Posoleucel) for the Treatment of Epstein-Barr Virus Associated Leiomyosarcoma in an Adult Kidney Transplant Recipient: A Case Report
R. Saranu¹, S. Nikiforow², V. Jo³, H. So², P. Stowe², S. Tripathi¹, F. Cardarelli⁴, A. Chandraker¹
¹Renal Division, Brigham and Women's Hospital, Boston, MA, ²Dana Farber Cancer Institute, Boston, MA, ³Pathology, Brigham and Women's Hospital, Boston, MA, ⁴Allovir, Cambridge, MA
*Purpose: Epstein-Barr virus (EBV)-associated leiomyosarcomas (EBV+LMS) are neoplasms rarely seen in solid organ transplant (SOT) recipients and currently lack effective treatment options. We present a…
2022 American Transplant Congress
Clinical Significance of the Living Kidney Donor Profile Index in Living Kidney Donors for Predicting of Post-Transplant Outcome: Korean Organ Transplantation Registry
J. Kim¹, D. Kim¹, S. Yoon¹, S. Kang¹, J. Kim¹, H. Hwang¹, K. Jeong¹, H. Ko², C. Jung³, D. Kim⁴, Y. Kim⁵, J. Yang⁶, C. Ahn⁷
¹Department of Nephrology, Kyung Hee University hospital, Seoul, Korea, Republic of, ²Department of Surgery, College of Medicine, Kyung Hee University, Seoul, Korea, Republic of, ³Department of Transplantation and Vascular Surgery, Korea University Anam Hospital, Seoul, Korea, Republic of, ⁴Department of Surgery, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Korea, Republic of, ⁵Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of, ⁶Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ⁷Department of Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: According to recent reports, a risk index for living donor kidney transplantation (LDKT) such as the Kidney donor profile index (KDPI), a non-invasive method…
2022 American Transplant Congress
Placement of COVID Positive Organs: An Early Analysis
A. M. Hawxby, R. Ketcham, J. P. Orlowski, R. Squires, C. Hostetler
Organ Recovery, LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: Until recently, donor COVID positivity was seen as a contraindication for donation or transplantation. Our OPO has recently adopted a practice in which organs…
2022 American Transplant Congress
Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Hutchins¹, M. Leick², M. Keck², J. S. McMullen²
¹Pharmacy, Houston Methodist Hospital, Houston, TX, ²Pharmacy, Nebraska Medicine, Omaha, NE
*Purpose: The purpose of this study is to determine the effect of delaying cytomegalovirus (CMV) prophylaxis to day of discharge or post-operative day (POD) 7…
2022 American Transplant Congress
Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients
E. Foster¹, A. Iaria¹, J. Negrelli², M. Fine², M. Yu², M. Liebo²
¹University of Illinois at Chicago, Chicago, IL, ²Loyola University Medical Center, Maywood, IL
*Purpose: The purpose of this study was to assess outcomes in heart transplant recipients who were converted from IR tacrolimus to LCPT. Limited data exists…
2022 American Transplant Congress
Successful Utilization of Advanced Diabetes Technology to Optimize Glucose Control as a Bridge to Simultaneous Liver and Pancreas Transplantation
M. M. Stumpf¹, S. Lee¹, E. Marriner¹, S. Rao¹, J. Oberholzer², S. Pelletier³
¹University of Virginia, Charlottesville, VA, ²University of Illinois at Chicago, Charlottesville, VA, ³University of Virginia Health System, Charlottesville, VA
*Purpose: We present the case of a 20 year old female with history of autoimmune hepatitis diagnosed in 2014, treated with tacrolimus, and insulin dependent…